Union Pharmacist results, Q1 2026
Net profit, assets, equity and cash flow for Q1 2026, against the same period a year earlier, from the published financial statements.
Net profit-860 thousandEGP · −210.3% vs the same period a year earlier
Total assets117 millionEGP · +37.5% vs the same period a year earlier
Shareholders' equity66.81 millionEGP · −4.1% vs the same period a year earlier
Operating cash flow2.69 millionEGP · +108.0% vs the same period a year earlier
In short
- Union Pharmacist's net profit for Q1 2026 was about -860 thousand EGP, down −210.3% from -277 thousand EGP in Q1 2025.
- Total assets at the end of Q1 2026 were about 117 million EGP, and shareholders' equity about 66.81 million EGP.
- Operating cash flow for Q1 2026 was positive at 2.69 million EGP.
Key lines against the same period a year earlier
This periodQ1 2025Change
Net profit-860 thousand-277 thousand−210.3%
Gross profit———
Total assets117 million85.38 million+37.5%
Total liabilities50.6 million15.69 million+222.6%
Shareholders' equity66.81 million69.7 million−4.1%
Total liabilities and equity117 million85.38 million+37.5%
Operating cash flow2.69 million-33.63 million+108.0%
Investing cash flow-86.64 thousand34.24 million−100.3%
Net change in cash2.6 million603 thousand+331.5%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Union Pharmacist's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy